EVENTIDE ASSET MANAGEMENT, LLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Filing Manager: EVENTIDE ASSET MANAGEMENT, LLC
Reporting Manager: Eventide Asset Management, LLC
Security: Zentalis Pharmaceuticals, Inc. Common Stock, $0.001 par value per share
Symbol: ZNTL
Shares outstanding: 71.3M shares
Disclosed Ownership: 4.48M shares
Ownership: 6.28%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 12:13 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title
Eventide Asset Management, LLC	6.28%	4.48M	4.48M	0	/s/ Peter J. Luiso	Peter J. Luiso, General Counsel
Finny Kuruvilla, M.D., Ph. D.	6.28%	4.48M	0	4.48M	/s/ Finny Kuruvilla, M.D., Ph. D.	Finny Kuruvilla, M.D., Ph. D.
Robin C. John	6.28%	4.48M	0	4.48M	/s/ Robin C. John	Robin C. John